Amy Sullivan - Mar 15, 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Signature
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
Stock symbol
IOBT
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 04:24 PM
Previous filing
Aug 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +280K $0.00 280K Mar 15, 2024 Common Stock 280K $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.